Status: Recruiting
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
The Phase I trial is evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of MBS8(1V270) in subjects with advanced solid tumours. The trial is designed to provide data for further clinical development of MBS8(1V270)
Participants needed: 106
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: MonTa Biosciences ApSUpdated: Jun 11, 2026Locations: 5
Eligibility criteria
Diagnosis of a histologically or cytologically confirmed solid tumour that was a... [+24]
Have had biologic, hormonal, anti-neoplastic chemotherapy, or radiation therapy... [+31]